AllianceBernstein
ALAB icon

AllianceBernstein’s Astera Labs ALAB Stock Holding History

AllianceBernstein’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111M Sell
1,017,008
-1,495,687
-60% -$397M 0.04% 356
2026
Q1 		$418M Buy
2,512,695
+334,900
+15% +$47.7M 0.14% 131
2025
Q4 		$362M Sell
2,177,795
-740,890
-25% -$124M 0.11% 140
2025
Q3 		$571M Sell
2,918,685
-3,472,895
-54% -$571M 0.18% 99
2025
Q2 		$578M Sell
6,391,580
-2,009,439
-24% -$159M 0.19% 96
2025
Q1 		$501M Buy
8,401,019
+4,478,741
+114% +$414M 0.18% 102
2024
Q4 		$520M Buy
3,922,278
+3,760,765
+2,328% +$353M 0.18% 95
2024
Q3 		$8.46M Sell
161,513
-403,642
-71% -$18.9M ﹤0.01% 1277
2024
Q2 		$34.2M Buy
565,155
+518,919
+1,122% +$36M 0.01% 718
2024
Q1 		$3.43M Buy
+46,236
New +$3.43M ﹤0.01% 1629

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AllianceBernstein's ALAB Position: Q2 2026 in Review

AllianceBernstein reduced its Astera Labs (ALAB) stake by 60% in Q2 2026, selling an estimated $397M and leaving 1,017,008 shares worth $111M. The position accounts for 0.04% of the portfolio, ranked #356.

AllianceBernstein first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. The position peaked at $578M in Q2 2025. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • AllianceBernstein held 1,017,008 shares of Astera Labs worth $111M as of Q2 2026.
  • AllianceBernstein sold 1,495,687 Astera Labs shares in Q2 2026, an estimated $397M.
  • Astera Labs made up 0.04% of AllianceBernstein's portfolio in Q2 2026, its #356 holding.
  • AllianceBernstein first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • AllianceBernstein's Astera Labs position peaked at $578M in Q2 2025.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.